Yee, Andrew J. http://orcid.org/0000-0003-3623-7491
Article History
Received: 7 April 2024
Revised: 2 June 2024
Accepted: 27 June 2024
First Online: 8 July 2024
Competing interests
: AJY has received consulting fees from AbbVie, Adaptive Biotechnologies, Amgen, BMS, Celgene, GSK, Johnson & Johnson (Janssen), Karyopharm, Oncopeptides, Pfizer, Prothena, Regeneron, Sanofi, Sebia, Takeda. AJY has received research funding (to the institution) from Amgen, BMS, and Johnson & Johnson (Janssen).